Tesofensine
| Tesofensine | |
|---|---|
| Salts [] | |
|---|---|
| Tesofensine tartrate | |
| Tesofensine citrate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 328.30 g/mol [1] |
| Predicted LogP | 4.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H23Cl2NO |
| IUPAC name | (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane |
| SMILES | CCOC[C@H]1[C@H]2CC[C@H](N2C)C[C@@H]1C3=CC(=C(C=C3)Cl)Cl |
| InChI | InChI=1S/C17H23Cl2NO/c1-3-21-10-14-13(9-12-5-7-17(14)20(12)2)11-4-6-15(18)16(19)8-11/h4,6,8,12-14,17H,3,5,7,9-10H2,1-2H3/t12-,13+,14+,17+/m0/s1 |
| InChIKey | VCVWXKKWDOJNIT-ZOMKSWQUSA-N |
| CAS number | 195875-84-4 |
| UNII | BLH9UKX9V1 |
| PubChem CID | 11370864 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 220 hours |
| Metabolism | 15–20% renal; hepatic: CYP3A4 |
| Excretion | Not applicable |
| Routes of administration | Oral |
Tesofensine (also known as Ns-2330, tesofensina, Ns2330, Ns 2330, Tesofensinum, A1ea1, orb1699151, Msk186418, Da-58430 or Ms-24909) is a stimulant substance of the phenylpropylamine class.
Chemistry
Salts []
Tesofensine is typically found in the form of its tartrate and citrate salts.
Stereochemistry []
Tesofensine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Tesofensine matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Tesofensine is a Serotonin-norepinephrine-dopamine-reuptake-inhibitor (SNDRI). SNDRIs are a class of psychoactive antidepressants. They act upon neurotransmitters in the brain, namely, serotonin, norepinephrine and dopamine. These three biogenic monoamines are associated with depression and increasing the availability in the brain is one method used to treat the condition. [1]
Subjective effects []
Legal status []
- United States: Tesofensine is a Investigational New Drug.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 11370864, Tesofensine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/11370864
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Tesofensine. UNII: BLH9UKX9V1. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/BLH9UKX9V1
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:01:51 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 14:01:47 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 14:01:47 |
| gsrs | ok | 2026-11-20 14:01:49 |
| hmdb | missing (no HMDB id) | 2026-11-20 14:01:47 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 14:01:51 |
| pubchem | ok | 2026-11-20 14:01:47 |
| missing (no r/tripreports posts mention it) | 2026-11-20 14:01:47 | |
| sider | missing (not in SIDER) | 2026-11-20 14:01:47 |
| structure | ok | 2026-11-20 14:01:47 |
| wikipedia | ok | 2026-11-20 14:01:47 |